Montelukast vs Trastuzumab
Montelukast vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Montelukast and Trastuzumab.
Mechanism of Action
Montelukast: Selective leukotriene D4 receptor antagonist.
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Montelukast β 2.7-5.5 hours; Trastuzumab β 28 days.
Chemical Properties
Molecular Formula: Montelukast β C35H36ClNO3S.
Molecular Weight: Montelukast β 586.1800 g/mol.
Type: Montelukast β Small molecule; Trastuzumab β Antibody.